Pounce Thrombectomy
Payments companies reported to CMS as associated with Pounce Thrombectomy. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Pounce Thrombectomy, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Pounce Thrombectomy
These are the largest totals companies reported as associated with Pounce Thrombectomy. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Gary Ansel | Columbus, OH | Interventional Cardiology | $484,271.30 |
| Lucas Ferrer Cardona | San Antonio, TX | Vascular Surgery | $64,105.84 |
| Aloke Finn | Baltimore, MD | Interventional Cardiology | $57,787.50 |
| Bruce Gray | Greenville, SC | Internal Medicine | $50,293.49 |
| Nachiket Patel | Mesa, AZ | Interventional Cardiology | $35,552.85 |
| Dean Ferrera | East Chicago, IN | Interventional Cardiology | $27,590.13 |
| David Dantzker | New York, NY | Pulmonary Disease | $19,061.48 |
| Kevin Onofrey | Detroit, MI | Vascular Surgery | $12,531.96 |
| Hady Lichaa | Murfreesboro, TN | Cardiovascular Disease | $8,632.53 |
| Joseph Campbell | Columbus, OH | Interventional Cardiology | $8,332.84 |
Prescribed Pounce Thrombectomy?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.